Seyedeh Hoda Hoda Alavizadeh

Dr. Seyedeh Hoda Hoda Alavizadeh


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
VMVahideh Mohammadzadeh
Vahideh Mohammadzadeh
NRNiloufar Rahiman
Niloufar Rahiman
HCHoracio Cabral
Horacio Cabral
SQSabina Quader
Sabina Quader
MZMohammad Reza Zirak
Mohammad Reza Zirak
SASeyedeh Hoda Hoda Alavizadeh
Seyedeh Hoda Hoda Alavizadeh

21 August 2022 in Journal of Drug Targeting
Verified
Journal Article
Closed access
SHSeyedeh Maryam Hosseinikhah
Seyedeh Maryam Hosseinikhah
FGFatemeh Gheybi
Fatemeh Gheybi
SMSeyedeh Alia Moosavian
Seyedeh Alia Moosavian
MSMohammad-Ali Shahbazi
Mohammad-Ali Shahbazi
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar
Cancer is one of the most lethal diseases, and limited available treatment options contribute to its high mortality rate. Exosomes are considered membrane-bound nanovesicles that include different molecules such as lipids, proteins, and nucleic acids. Virtually most cells could release exosomes via exocytosis in physiological and pathological conditions. Tumor-derived exosomes (TDEs) play essential roles in tumorigenesis, proliferation, progression, metastasis, immune escape, and chemoresistance by transferring functional biological cargos, triggering different autocrine, and paracrine signaling cascades. Due to their antigen-presenting properties, exosomes are widely used as biomarkers and drug carriers and have a prominent role in cancer immunotherapy. They offer various advantages in carrier systems (e.g., in chemotherapy, siRNA, and miRNA), delivery of diagnostic agents owing to their stability, loading of hydrophobic and hydrophilic agents, and drug targeting. Novel exosomes-based carriers can be generated as intelligent systems using various sources and crosslinking chemistry extracellular vesicles (EVs). Exosomes studded with targeting ligands, including peptides, can impart in targeted delivery of cargos to tumor cells. In this review, we comprehensively summarized the important role of tumor-derived exosomes in dictating cancer pathogenesis and resistance to therapy. We have therefore, investigated in further detail the pivotal role of tumor-derived exosomes in targeting various cancer cells and their applications, and prospects in cancer therapy and diagnosis. Additionally, we have implicated the potential utility and significance of tumor exosomes-based nanoparticles as an efficient and novel therapeutic carrier and their applications in treating advanced cancers. Graphical

1 April 2021 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SHSaeed Mohammadian Haftcheshmeh
Saeed Mohammadian Haftcheshmeh
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari
MMMohammad Mashreghi
Mohammad Mashreghi
AMAmin Mehrabian
Amin Mehrabian
SASeyedeh Hoda Hoda Alavizadeh
Seyedeh Hoda Hoda Alavizadeh
FGFatemeh Gheybi
Fatemeh Gheybi

20 July 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
FGFatemeh Gheybi
Fatemeh Gheybi
AKAlireza Khooei
Alireza Khooei
AHAzam Hoseinian
Azam Hoseinian
MDMaham Doagooyan
Maham Doagooyan
KHKebria Houshangi
Kebria Houshangi
SASeyedeh Hoda Hoda Alavizadeh
Seyedeh Hoda Hoda Alavizadeh

21 June 2022 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
EMElaheh Mirhadi
Elaheh Mirhadi
FGFatemeh Gheybi
Fatemeh Gheybi
NMNadya Mahmoudi
Nadya Mahmoudi
MHMaliheh Hemmati
Maliheh Hemmati
FSFatemeh Soleymanian
Fatemeh Soleymanian
SASeyedeh Hoda Hoda Alavizadeh
Seyedeh Hoda Hoda Alavizadeh